key: cord-0827783-n5qfwl57 authors: Charoenngam, Nipith; Shirvani, Arash; Holick, Michael F. title: Vitamin D and Its Potential Benefit for the COVID-19 Pandemic date: 2021-03-17 journal: Endocr Pract DOI: 10.1016/j.eprac.2021.03.006 sha: 4660a51e06ef55c7e4c37ee20eb93177cb32bb22 doc_id: 827783 cord_uid: n5qfwl57 Vitamin D is known not only for its importance for bone health, but also for its biologic activities on other many other organ systems. This is due to the presence of the vitamin D receptor (VDR) in various types of cells and tissues, including the skin, skeletal muscle, adipose tissue, endocrine pancreas, immune cells and blood vessels. Experimental studies have shown that vitamin D exerts several actions that are thought to be protective against COVID-19 infectivity and severity. These include the immunomodulatory effects on the innate and adaptive immune systems, the regulatory effects on renin-angiotensin-aldosterone-system in the kidneys and the lungs, and the protective effects against endothelial dysfunction and thrombosis. Prior to the COVID-19 pandemic, studies have shown that vitamin D supplementation is beneficial in protecting against risk of acquiring acute respiratory viral infection and may improve outcomes in sepsis and critically ill patients. There are a growing number of data connecting COVID-19 infectivity and severity with vitamin D status, suggesting a potential benefit of vitamin D supplementation for primary prevention or as an adjunctive treatment of COVID-19. Although the results from most ongoing randomized clinical trials aiming to prove the benefit of vitamin D supplementation for these purposes are still pending, there is no downside to increasing vitamin D intake and having sensible sunlight exposure to maintain serum 25-hydroxyvitamin D at least 30 ng/mL (75 nmol/L) and preferably at 40 – 60 ng/mL (100 – 150 nmol/L) to minimize the risk of COVID-19 infection and its severity. venous thrombosis, multi-organ failure, septic shock, among others (4, 5). Factors known to 55 be associated with increased susceptibility to severe outcomes are advanced age, cancer, 56 immunocompromised state, chronic kidney disease, chronic respiratory disease, cardio-57 metabolic disorders and smoking (6). The elderly, African Americans, patients with obesity 58 and nursing home residents (7, 8) have disproportionately higher rates of infection, morbidity 59 and mortality from COVID-19. These populations are also known as being at high risk for 60 vitamin D deficiency (9-12). Thus, vitamin D deficiency could potentially contribute to 61 higher COVID-19 positivity, morbidity and mortality rates appreciated in these populations. 62 Vitamin D is not only known for its importance for bone health, but also recognized 63 for its potential protective effects against multiple chronic diseases as well as its 64 immunomodulatory activities (10, 11, 13). With the global prevalence of vitamin D Thirty healthy adults with vitamin D insufficiency [25(OH)D 20 -<30 ng/mL or 50 -<75 110 nmol/L] or deficiency [25(OH)D <20 ng/mL or <50 nmol/L] were randomized to receive 111 600, 4,000 or 10,000 IU per day of vitamin D 3 for 6 months and were found to have dose-112 dependent alteration in broad gene expression with 162, 320 and 1,289 genes up-or down-113 regulated in their PBMCs, respectively (33). Equally interesting if not more is that some 114 individuals might respond to vitamin D more or less than others as high inter-individual 115 difference in responsiveness to vitamin D supplementation has been observed (Figure 2) . In (1-9) (60). This mechanism is thought to help mitigate bradykinin storm, which has been 174 shown to underlie the multiple organ dysfunction in COVID-19 (60). normally circulates at about 100 times higher concentration than 1,25(OH) 2 D 3 , was at least 182 10 times more potent than 1,25(OH) 2 D 3 and more than 1,000 times more potent than Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and 387 complications of coronavirus disease 2019 (COVID-19) COVID-19): A Review Risk factors for Covid-19 severity and fatality: a 392 structured literature review COVID-19, Social Determinants Past, Present, and Future, and African 394 Is ethnicity linked to incidence or outcomes of covid-396 19? Sunlight and Vitamin D: A global perspective for health Vitamin D for skeletal and non-skeletal health: What 400 we should know Vitamin D deficiency Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice 404 guideline Immunologic Effects of Vitamin D on Human Health and 406 Disease High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic 408 proceedings Redefining vitamin D insufficiency Hypovitaminosis D in medical inpatients Is There an Association Between 515 COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations. 516 Clinical Infectious Diseases D3 Suppresses Renin Gene Transcription by Blocking the Activity of the Cyclic AMP 519 Response Element in the Renin Gene Promoter * Vitamin D alleviates 522 lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system Renin-angiotensin-aldosterone system blockade for 525 cardiovascular diseases: current status A mechanistic model 527 and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm Dietary Vitamin D 530 and Its Metabolites Non-Genomically Stabilize the Endothelium Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial 533 Stability Emerging Role of Vitamin D and its Associated 535 Molecules in Pathways Related to Pathogenesis of Thrombosis Illuminating vitamin D effects on B cells--the 537 multiple sclerosis perspective 540 66. Hope-Simpson RE. The role of season in the epidemiology of influenza Global Seasonality of Human Seasonal Coronaviruses: A Clue for 543 Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2? The Journal 544 of Infectious Diseases Shortcomings of Vitamin D-Based Model 549 Simulations of Seasonal Influenza Environmental predictors of seasonal influenza epidemics across temperate and tropical climates Serum 25-556 hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults Association of vitamin D 559 deficiency with severity of acute respiratory infection: A case-control study in New Zealand children Randomized trial of vitamin D 562 supplementation to prevent seasonal influenza A in schoolchildren Vitamin D 565 supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis 566 of individual participant data Sepsis: A Review of Advances in 568 Management Vitamin D deficiency as a risk 570 factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit 571 Care Correlation of Serum Vitamin D Level 573 with Mortality in Patients with Sepsis Inflammatory 575 conditions induce IRES-dependent translation of cyp24a1 Plasma concentration of Gc-577 globulin is associated with organ dysfunction and sepsis after injury High Dose Vitamin D 580 Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized 581 Controlled Trial Trying to identify 583 who may benefit most from future vitamin D intervention trials: a post hoc analysis from the 584 VITDAL-ICU study excluding the early deaths Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The 590 GERIA-COVID Quasi-Experimental Study Vitamin D 592 and survival in COVID-19 patients: A quasi-experimental study SARS-CoV-2 positivity rates associated with 595 circulating 25-hydroxyvitamin D levels Association of Vitamin D Status and 597 Other Clinical Characteristics With COVID-19 Test Results Nutritional status of patients with COVID-600 19 Low plasma 602 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-603 based study Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection. The 606 No significant association between vitamin D and COVID-19. A 608 retrospective study from a northern Italian hospital Vitamin D 611 concentrations and COVID-19 infection in UK Biobank Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Critical 615 Reviews in Food Science and Nutrition Vitamin D -620 contrary to vitamin K -does not associate with clinical outcome in hospitalized COVID-19 patients Impact of Serum 25(OH) Vitamin D Level on Mortality in Patients with 623 COVID-19 in Turkey Vitamin D Status and 625 COVID-19 Clinical Outcomes in Hospitalized Patients Factors Associated with Hospitalization and 627 Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients. medRxiv : the 628 preprint server for health sciences Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with 633 COVID-19: A Cross-Sectional Multi-Centre Observational Study Vitamin D Deficiency: Consequence or Cause of Obesity? 638 Medicina (Kaunas) Prevalence of abnormal 640 serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of 641 the study to evaluate early kidney disease Vitamin D 643 sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical 644 outcomes in patients with COVID-19 infection Letter to the Editor: Vitamin D 648 deficiency in COVID-19: Mixing up cause and consequence Vitamin D status 650 and outcomes for hospitalised older patients with COVID-19 Effect of calcifediol treatment and best available therapy versus best available 654 therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A 655 pilot randomized clinical study High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: 658 A Randomized Clinical Trial Resurrection of vitamin D deficiency and rickets Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19 Vitamin 665 D status indicators in indigenous populations in East Africa Sunlight and Vitamin D: A global perspective for health The Death D-fying Vitamin Serum 25-Hydroxyvitamin D 673 Values and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort Study. Mayo 674 Vitamin D for health: a global perspective. Mayo Clinic 676 proceedings The importance of body 678 weight for the dose response relationship of oral vitamin D supplementation and serum 25-679 hydroxyvitamin D in healthy volunteers Vitamin D for Health: A Global Perspective 683 Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: 684 rationale for clinical management Magnesium status and 686 supplementation influence vitamin D status and metabolism: results from a randomized trial ACE2 expression in the renal tubular cells, which is thought to be protective against COVID-713 associated kidney injury by reducing the viral direct cytopathic effects on the cell Abbreviations: 1,25-dihydroxyvitamin D; 1,25(OH) 2 D; Angiotensin converting enzyme: 715 ACE; Angiotensin converting enzyme 2: ACE2; AT 1 receptor: Angiotensin II type 1 receptor Severe acute respiratory distress syndrome coronavirus 2 (Copyright Holick SARS-CoV-2 nucleic acid amplification test positivity rates and circulating 25-719 hydroxyvitamin D levels by (A) latitude region, (B) Predominately Black non-Hispanic Hispanic zip codes, (C) age group and (D) sex. Smooth lines 721 represent the weighted second order polynomial regression fit to the data associating 722 circulating 25(OH)D levels (x-axis) and SARS-CoV-2 positivity rates (y-axis)